Literature DB >> 30179525

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary.

Randy A Taplitz1, Erin B Kennedy1, Christopher R Flowers1.   

Abstract

Entities:  

Year:  2018        PMID： 30179525     DOI： 10.1200/JOP.18.00366

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  5 in total

1.  Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.

Authors:  Catherine C Braga; Randy A Taplitz; Christopher R Flowers
Journal:  J Oncol Pract       Date:  2019-01       Impact factor: 3.840

2.  Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy.

Authors:  Seth A Climans; Warren P Mason; Eva Grunfeld; Kelvin Chan
Journal:  J Neurooncol       Date:  2022-08-06       Impact factor: 4.506

3.  Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy.

Authors:  Seth A Climans; Eva Grunfeld; Warren P Mason; Kelvin K W Chan
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

4.  Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review.

Authors:  Susannah L McKay; Angela Guo; Steven A Pergam; Kathleen Dooling
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

5.  Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir.

Authors:  Angioletta Lasagna; Antonio Piralla; Simona Secondino; Paolo Sacchi; Fausto Baldanti; Raffaele Bruno; Paolo Pedrazzoli
Journal:  Front Med (Lausanne)       Date:  2022-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.